DOCSLIB.ORG

Drugwatch AMT Factsheet

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Drugwatch AMT Factsheet 48 factsheet Dosage: may feel an energy drain, low mood Oral Smoked or experience flu-like symptoms and Threshold 5-15mg Threshold 2mg AMT general tiredness/lethargy. This typically Light 10-20mg Light 4-5mg happens a day or two after use, which Common 20-40mg Common 6-10mg some users call the “Tuesday blues”. Strong 40-60mg Strong 10-20mg Some anecdotal reports suggest AMT has Heavy 60-100mg Drug overview: less of a hangover than drugs such as Alpha-methyltryptamine (MT/AMT) MDMA although this is not an indication Pellets are reported to contain a dosage is a currently legal new psychoactive of long term safety. of 30mg. substance. It is a long acting, synthetic Patterns of use: psychedelic. Typical effects and side effects Patterns of use appear to be similar to These are some of the typical effects and Background: drugs such as LSD. There seems to be side effects experienced by people who AMT was originally developed as an little tendency to re-dose quickly unless a use AMT, not everyone will experience antidepressant in the 1960s by the user believes they have not taken enough all effects listed and many can be dose company UpJohn. In the 1990s AMT to experience full effects. dependent. resurfaced as a drug of recreational use Long term effects/known harms: made available over the internet. It was Physical: Mental: AMT is a relatively unknown substance first seen in the UK in February 2011. • Increase in • Mood and little is known about the long- energy enhancement Appearance: term effects and potential harms. AMT • Increased heart • Empathy AMT is an off white or yellowish/orange has the potential to cause serotonin rate • Visual patterning powder. The consistency can be either toxicity especially at high doses or when • Blurred vision • Closed eye clumpy or fine. It is also found in tablet mixed with other substances especially • Restlessness visuals (CEV) form. These are commonly referred to stimulants. AMT in conjunction with anti • Yawning • Mild open eye as pellets to avoid accusations that they depressant/anxiety medications (SSRI/ • Dilated pupils visuals (OEV) are medicinal products. They are small SNRI) has the potential to precipitate this • Decreased • Music blue pellets typically containing 30mg condition. appetite and appreciation freebase powder. Serotonin toxicity can be fatal if not difficulty eating • Anxiety AMT or 5-IT has been discovered in recognised and dealt with both quickly • Vision obscuring • Paranoia tablets sold as Ecstasy including pale and effectively. Symptoms include visuals at high • Agitation pink tablets with a cherry logo and white hyperthermia (overheating), hyperreflexia doses • Panic tablets with a Mitsubishi logo but due (over responsive reflexes), clonus • Nausea and • Mental to the complications of distinguishing (involuntary muscular contractions and vomiting confusion between the two in analysis it is not relaxations), hypertension (high blood • Impaired • Repetitive confirmed which is the definite active pressure), dysphoria (mental distress) coordination thoughts ingredient in these tablets. and mydriasis (dilated pupils). Due • Muscle aches • Racing mind to muscle tension being triggered by Cost: • Headache • Disturbed the condition, there is a potential of Pellets cost approximately £5 per • Jaw clenching dreams developing Rhabdomyolysis (muscle 30mg pellet. The powder form (purity • Insomnia tissue breakdown) which can cause unknown) costs approx £30 per gram severe kidney damage and can be fatal. and is available in amounts from 100mg Onset, duration and after effects: It is therefore dangerous to restrain at £7.50. Oral doses have an onset of 30-120 individuals, as increased agitation minutes and peak at 3-5 hours. The Route of administration: will lead to increased muscle tension duration is generally 10-14 hours AMT is often consumed orally, either by trying to break free from restraints. although higher doses can last longer. swallowing pellets, wrapping powder Treatment can include cooled IV fluids, After effects can be felt for a further in a cigarette paper (bombing) or by benzodiazepines to control agitation, 1-5 hours. As the effects can take over taking a small bit of powder from tip of a rapid cooling via ice packs, oral 2 hours to fully develop orally, it is not moistened finger (dabbing).T he powder cyproheptadine (anti-histamine with uncommon for users to re-dose in error form can be smoked; the onset is much anti-serotonergenic properties) and anti- thinking they have not taken enough faster by this method. psychotic medication in severe cases. initially. When smoked, the onset is It is possible to inject this substance Two alerts regarding AMT were issued significantly quicker at 10-30 seconds or administer rectally, although these in 2012 after information was received with typical duration between 8-12 methods appear to be rare for this regarding deaths in the United Kingdom hours. substance. Due to the intensity and and Norway. Two cases indicated that or dose/response curve for AMT, IV Comedown effects AMT was the only drug found in the administration would likely be very Some users report experiencing a system and the other included multiple dangerous. stimulant-like comedown, where they substances. 28 | DRUGLINK JANUARY/FEBRUARY 2014.
Load more

Recommended publications
  • American Civil Liberties Union
    WASHINGTON LEGISLATIVE OFFICE March 19, 2012 Honorable Patti B. Saris, Chair United States Sentencing Commission One Columbus Circle, N.E. Suite 2-500, South Lobby Washington, D.C. 2002-8002 Re: ACLU Comments on Proposed Amendments to Sentencing Guidelines, Policy Statements, and Commentary due on March 19, 2012 AMERICAN CIVIL LIBERTIES UNION WASHINGTON Dear Judge Saris: LEGISLATIVE OFFICE 915 15th STREET, NW, 6 TH FL WASHINGTON, DC 20005 With this letter the American Civil Liberties Union (“ACLU”) provides T/202.544.1681 commentary on the Amendments to the U.S. Sentencing Guidelines F/202.546.0738 WWW.ACLU.ORG (“Guidelines”) proposed by the Commission on January 19, 2012. The American Civil Liberties Union is a non-partisan organization with more than LAURA W. MURPHY DIRECTOR half a million members, countless additional activists and supporters, and 53 NATIONAL OFFICE affiliates nationwide dedicated to the principles of liberty, equality, and justice 125 BROAD STREET, 18 TH FL. embodied in our Constitution and our civil rights laws. NEW YORK, NY 10004-2400 T/212.549.2500 These comments address four issues that the Commission has asked for OFFICERS AND DIRECTORS SUSAN N. HERMAN public comment on by March 19, 2012. First, the ACLU encourages the PRESIDENT Commission to reject the adoption of the 500:1 MDMA marijuana equivalency ANTHONY D. ROMERO ratio for N-Benzylpiperazine, also known as BZP, (BZP) and make substantial EXECUTIVE DIRECTOR downward revisions to the MDMA marijuana equivalency ratio. Also, we urge ROBERT REMAR the Commission to respect the principles of proportionality and due process in TREASURER deciding how and whether to amend the Guideline for unlawfully entering or remaining in the country.
    [Show full text]
  • Ecstasy Or Molly (MDMA) (Canadian Drug Summary)
    www.ccsa.ca • www.ccdus.ca November 2017 Canadian Drug Summary Ecstasy or Molly (MDMA) Key Points Ecstasy and molly are street names for pills or tablets that are assumed to contain the active ingredient 3,4-methylenedioxy-N-methamphetamine (MDMA). Although most people consuming ecstasy or molly expect the main psychoactive ingredient to be MDMA, pills, capsules and powder sold as ecstasy or molly frequently contain other ingredients (such as synthetic cathinones or other adulterants) in addition to MDMA and sometimes contain no MDMA at all. The prevalence of Canadians aged 15 and older reporting past-year ecstasy use is less than 1%. 1 in 25 Canadian youth in grades 10–12 have reported using ecstasy in the past 12 months. Introduction Ecstasy and molly are street names for pills, capsules or powder assumed to contain MDMA (3,4- methylenedioxy-N-methamphetamine), a synthetically derived chemical that is used recreationally as a party drug. Pills are typically coloured and stamped with a logo. These drugs are made in illegal laboratories, often with a number of different chemicals, so they might not contain MDMA or contain MDMA in amounts that vary significantly from batch to batch. Other active ingredients found in tablets sold as ecstasy or molly in Canada in 2016–2017 include synthetic cathinones or “bath salts” such as ethylone, methylenedioxyamphetamine (MDA) and its precursor methylenedioxyphenylpropionamide (MMDPPA). Other adulterants reported were caffeine, procaine, methylsulfonylmethane (MSA)and methamphetamine.1 In 2011–2012, paramethoxymethamphetamine (PMMA) was present in pills sold as ecstasy in Canada. This adulteration resulted in the deaths of 27 individuals in Alberta and British Columbia over an 11-month period.2 Effects of Ecstasy Use The effects of ecstasy are directly linked to the active ingredients in the pill.
    [Show full text]
  • Synergistic Discriminative Effect of LSD and MDMA
    European Journal of Pharmacology 341Ž. 1998 131±134 Short Communication `Candyflipping': Synergistic discriminative effect of LSD and MDMA Martin D. Schechter ) Department of Pharmacology, Northeastern Ohio UniÕersities College of Medicine, P.O. Box 95, Rootstown, OH 44272-0095, USA Received 27 October 1997; accepted 28 October 1997 Abstract The co-administration of D-lysergic acid diethylamideŽ. LSD; `Acid' and 3,4-methylenedioxymethamphetamine Ž MDMA; `Ecstasy'; `XTC'. , has reached a prevalence that has allowed for the street terminology `candyflipping' to describe the combination. Internet sites indicate a significant enhancement of central effects with their simultaneous use. In this preliminary observation, male Fawn-Hooded rats were trained to discriminate 1.5 mgrkg MDMA and were, subsequently, tested with doses of MDMAŽ.Ž 0.15 mgrkg or LSD 0.04 mgrkg. that each produced a saline-like response. Co-administration of these doses of MDMA and LSD synergized to produce a maximal MDMA-like response. The possible mechanism for synergistic action upon central serotonergic neurons is discussed to explain the observed effect. q 1998 Elsevier Science B.V. Keywords: Drug discrimination; MDMA; LSD Ž.D-lysergic acid diethylamide ; Candyflipping; Synergism; Ž. Rat 1. Introduction will be citedŽ. http:rrwww sites . This information may be seen to be of suspicious scientific merit yet this source `Candyflipping' is the `street' term for the co-adminis- may allow for extensive subjective and unsolicited infor- tration of D-lysergic acid diethylamideŽ. LSD and 3,4- mation to permit insights into the popular trends in the methylenedioxymethamphetamineŽ. MDMA . The scien- drug culture. Having stated these caveats, the co-adminis- tific literature on the effects of using these two Drug tration of MDMA with LSD has been suggested to ``go Enforcement AgencyŽ.
    [Show full text]
  • Methamphetamine & Opioid Response Initiative
    Billings Metro VISTA Project Methamphetamine & Opioid Response Initiative: A Community Assessment July 2019 AmeriCorps VISTAs: Nick Fonte and Amy Trad Table of Contents EXECUTIVE SUMMARY ......................................................................................................................................... 3 INTRODUCTION ....................................................................................................................................................... 4 Section 1: Area of Study ............................................................................................................................................ 4 Section 2: Methamphetamine vs. Opioids ................................................................................................................. 5 KEY STAKEHOLDERS ............................................................................................................................................ 6 Section 1: Community Organizations/Non-profits .................................................................................................... 6 Section 2: Statewide and Local Initiatives ................................................................................................................ 9 RELEVANT DATA ................................................................................................................................................... 11 Section 1: Methamphetamine and Opioids in the News .........................................................................................
    [Show full text]
  • From Sacred Plants to Psychotherapy
    From Sacred Plants to Psychotherapy: The History and Re-Emergence of Psychedelics in Medicine By Dr. Ben Sessa ‘The rejection of any source of evidence is always treason to that ultimate rationalism which urges forward science and philosophy alike’ - Alfred North Whitehead Introduction: What exactly is it that fascinates people about the psychedelic drugs? And how can we best define them? 1. Most psychiatrists will define psychedelics as those drugs that cause an acute confusional state. They bring about profound alterations in consciousness and may induce perceptual distortions as part of an organic psychosis. 2. Another definition for these substances may come from the cross-cultural dimension. In this context psychedelic drugs may be recognised as ceremonial religious tools, used by some non-Western cultures in order to communicate with the spiritual world. 3. For many lay people the psychedelic drugs are little more than illegal and dangerous drugs of abuse – addictive compounds, not to be distinguished from cocaine and heroin, which are only understood to be destructive - the cause of an individual, if not society’s, destruction. 4. But two final definitions for psychedelic drugs – and those that I would like the reader to have considered by the end of this article – is that the class of drugs defined as psychedelic, can be: a) Useful and safe medical treatments. Tools that as adjuncts to psychotherapy can be used to alleviate the symptoms and course of many mental illnesses, and 1 b) Vital research tools with which to better our understanding of the brain and the nature of consciousness. Classifying psychedelic drugs: 1,2 The drugs that are often described as the ‘classical’ psychedelics include LSD-25 (Lysergic Diethylamide), Mescaline (3,4,5- trimethoxyphenylathylamine), Psilocybin (4-hydroxy-N,N-dimethyltryptamine) and DMT (dimethyltryptamine).
    [Show full text]
  • Ecstasy Or Molly, Is a Synthetic Psychoactive Drug
    DRUG ENFORCEMENT ADMINISTRATION THE FACTS ABOUT MDMA Ecstasy &Molly DEA PHOTO What is it? MDMA, (3,4-methylenedioxy- methamphetamine), known as Ecstasy or Molly, is a synthetic psychoactive drug. Ecstasy is the pill form of MDMA. Molly is the slang for “molecular” that refers to the powder or crystal form of MDMA. Molly is often mixed with other drugs and substances and is not pure MDMA or safe to use. How is it used? MDMA or Ecstasy is taken orally in pill or tablet form. These pills can be in different colors with images on them. Molly is taken in a gel capsule or snorted. What does MDMA do to the body and mind? • As a stimulant drug, it increases heart rate and blood pressure. Users may experience muscle tension, involuntary teeth clenching, nausea, blurred vision, faintness, chills, or sweating • It produces feelings of increased energy, euphoria, emotional warmth, empathy, and distortions in sensory and time perception. • Feelings of sadness, anxiety, depression and memory difficulties are other effects. • It can seriously deplete serotonin levels in the brain, causing confusion and sleep problems. Did you know? • DEA has labeled MDMA as a Schedule I drug, meaning its abuse potential is high and it has no approved medical use. It is illegal in the U.S. • In high doses, MDMA can affect the body’s ability to regulate temperature, which can lead to serious health complications and possible death. • Teens are using less MDMA. Teens decreased their past year use of MDMA from 1.9% in 2010 to 1.2% of teens using 2012.
    [Show full text]
  • MDMA) Cause Selective Ablation of Serotonergic Axon Terminals in Forebrain: Lmmunocytochemical Evidence for Neurotoxicity
    The Journal of Neuroscience, August 1988, 8(8): 2788-2803 Methylenedioxyamphetamine (MDA) and Methylenedioxymetham- phetamine (MDMA) Cause Selective Ablation of Serotonergic Axon Terminals in Forebrain: lmmunocytochemical Evidence for Neurotoxicity E. O’Hearn,” G. Battaglia, lab E. B. De Souza,’ M. J. Kuhar,’ and M. E. Molliver Departments of Neuroscience, and Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, and ‘Neuroscience Branch, Addiction Research Center, National Institute on Drug Abuse, Baltimore, Maryland 21224 The psychotropic amphetamine derivatives 3,4-methylene- The synthetic amphetamine derivatives 3,4-methylenedioxy- dioxyamphetamine (MDA) and 3,4-methylenedioxymetham- amphetamine (MDA) and 3,4-methylenedioxymethamphet- phetamine (MDMA) have been used for recreational and amine (MDMA) are potent mood-altering drugs that have at- therapeutic purposes in man. In rats, these drugs cause large tained public interest (Seymour, 1986) due to their widespread, reductions in brain levels of serotonin (5HT). This study self-administration by young adults (e.g., Klein, 1985). These employs immunocytochemistry to characterize the neuro- drugs have also been proposed for medical use in psychotherapy toxic effects of these compounds upon monoaminergic neu- because they produce augmentation of mood and enhanced in- rons in the rat brain. Two weeks after systemic administra- sight (Naranjo et al., 1967; Yensen et al., 1976; Di Leo, 198 1; tion of MDA or MDMA (20 mg/kg, s.c., twice daily for 4 d), Greer and Tolbert, 1986; Grinspoon and Bakalar, 1986). How- there is profound loss of serotonergic (5HT) axons through- ever, concern has been raised about the safety of these com- out the forebrain; catecholamine axons are completely pounds based on evidence that they may be toxic to brain seroto- spared.
    [Show full text]
  • Problematic Use of Nitrous Oxide by Young Moroccan–Dutch Adults
    International Journal of Environmental Research and Public Health Article Problematic Use of Nitrous Oxide by Young Moroccan–Dutch Adults Ton Nabben 1, Jelmer Weijs 2 and Jan van Amsterdam 3,* 1 Urban Governance & Social Innovation, Amsterdam University of Applied Sciences, P.O. Box 2171, 1000 CD Amsterdam, The Netherlands; [email protected] 2 Jellinek, Department High Care Detox, Vlaardingenlaan 5, 1059 GL Amsterdam, The Netherlands; [email protected] 3 Amsterdam University Medical Center, Department of Psychiatry, University of Amsterdam, P.O. Box 22660, 1100 DD Amsterdam, The Netherlands * Correspondence: [email protected] Abstract: The recreational use of nitrous oxide (N2O; laughing gas) has largely expanded in recent years. Although incidental use of nitrous oxide hardly causes any health damage, problematic or heavy use of nitrous oxide can lead to serious adverse effects. Amsterdam care centres noticed that Moroccan–Dutch young adults reported neurological symptoms, including severe paralysis, as a result of problematic nitrous oxide use. In this qualitative exploratory study, thirteen young adult Moroccan–Dutch excessive nitrous oxide users were interviewed. The determinants of problematic nitrous oxide use in this ethnic group are discussed, including their low treatment demand with respect to nitrous oxide abuse related medical–psychological problems. Motives for using nitrous oxide are to relieve boredom, to seek out relaxation with friends and to suppress psychosocial stress and negative thoughts. Other motives are depression, discrimination and conflict with friends Citation: Nabben, T.; Weijs, J.; van or parents. The taboo culture surrounding substance use—mistrust, shame and macho culture— Amsterdam, J. Problematic Use of frustrates timely medical/psychological treatment of Moroccan–Dutch problematic nitrous oxide Nitrous Oxide by Young users.
    [Show full text]
  • 10 Facts About MDMA
    10 Facts About MDMA August 2015 1. What is MDMA? and a desire to intensify these feelings by dancing, talking and touching. MDMA, often referred to as “ecstasy” or “molly”, is short for 3,4 methylenedioxymethamphetamine, a A typical dose of 80 - 125 mg lasts three to six hours. psychoactive drug derived from safrole oil. MDMA Some people experience nausea at the outset, but produces effects that resemble both stimulants and after about 45 minutes, report feelings of relaxation psychedelics, as well as its signature effect: a feeling and clarity. MDMA also causes dilation of the pupils of connectedness. It impacts brain function primarily and, often, sensitivity to light, as well as possible jaw- releasing the neurotransmitter serotonin, and also clenching, tooth-grinding, muscle tension, faintness, temporarily inhibits its reuptake. MDMA is usually and chills or sweating. taken orally, whether in pressed pill form, powder or crystal; or sometimes snorted. After the drug wears off, the theory from preclinical studies is that brain levels of serotonin (a chemical MDMA was originally synthesized in 1912 by the drug responsible for maintaining mood balance) are company Merck.1 However, its psychoactive effects depleted, which can lead in some cases to sadness, weren’t widely discovered until 1976 when Alexander anxiety, depression and sleep problems.4 If they occur, Shulgin developed a new synthesis method, tested the these symptoms arise in the several days that follow. drug on himself, and shared it with a few friendly Generally, they abate within a week, though frequency psychotherapists.2 Because of the drug’s effects of of use and higher doses can slow or stop this increasing empathy and reducing fear, it started to be process.5 used in psychotherapy practices in the 1970s and early 80s, as well as recreationally.
    [Show full text]
  • Getting Through Amphetamine Withdrawal – a Guide for People
    Amphetamine_wdl_220404.qxd 28/04/2004 12:19 PM Page i GETTING THROUGH AMPHETAMINE WITHDRAWAL A guide for people trying to stop amphetamine use Amphetamine_wdl_220404.qxd 28/04/2004 12:19 PM Page ii GETTING THROUGH AMPHETAMINE WITHDRAWAL CONTENTS About this book x Making the decision to stop using amphetamines x Amphetamine withdrawal x What is withdrawal? x How long will the symptoms last? What kinds of symptoms will I have? x Getting started x Organise a safe environment x Organise support x Structure your day x The role of medication x Getting through withdrawal x Cravings x Sleep x September 1996 Relaxing x Revised May 2004 Mood swings x © Turning Point Alcohol and Drug Centre Inc. Strange thoughts x 54-62 Gertrude Street, Fitzroy VIC 3065 Eating again x T: 03 8413 8413 Aches and pains x F: 03 9416 3420 High-risk situations x Counselling x E: [email protected] It’s all too much x www.turningpoint.org.au Sex and withdrawal x Original edition by Dr Nik Lintzeris, Dr Adrian Dunlop and After withdrawal x David Thornton What next? x Updated (2004) by Dr Adrian Dunlop, Sandra Hocking, Dr Getting back on track if you ‘slip up’ x Nicole Lee and Peter Muhleisen Notes for supporters x Cartoonist: Mal Doreian Useful contact numbers x ISBN 0_958 6979_1_4 1 Amphetamine_wdl_220404.qxd 28/04/2004 12:19 PM Page 2 GETTING THROUGH AMPHETAMINE WITHDRAWAL MAKING THE DECISION TO STOP USING AMPHEATMINES ABOUT THIS BOOK This book is written for people who are thinking about You may find it helpful to make a list of the positives and the or trying to stop using amphetamines, even if just for a negatives about using amphetamines.
    [Show full text]
  • Expert Peer Review No.2 Agenda Item 4.20: Alpha-Methyltryptamine (AMT)
    Expert peer review No.2 Agenda item 4.20: Alpha‐methyltryptamine (AMT) Expert Committee on Drug Dependence Thirty‐sixth Meeting Geneva, 16‐20 June 2014 1. Comments based on the review report a. Evidence on dependence and abuse potential AMT has potential for abuse because it shares many similarities to other hallucinogenic tryptamines and MDMA. It produces amphetamine‐like mood elevating effect and indeed AMT is used as a substitute for MDMA. Human subjects using AMT report euphoria, stimulation, visual effects such as blurry vision, bright colors, after images, primarily hallucinogenic effects. Lower doses of AMT produce stimulant effects and increasing the dose causes more hallucinogenic effects. In animals, AMT produced discriminative stimulus effects similar to DOM and MDMA. As a class, tryptamines are generally not physical or psychological dependence producing. Users report a lack of withdrawal effects following discontinuation of use, even though some cases reported short period of tolerance or feelings of depression following AMT use. Dependence or tolerance potential of AMT is essentially unknown without human pharmacokinetic and controlled pharmacology data. b. Risks to individual and society because of misuse Tryptamines are considered not to produce life‐threatening cardiovascular, renal or hepatic toxicity because of their lack of affinity for the relative targets and receptor, but there have been deaths associated with AMT use especially in combination with other agents such as 3,4‐methylenedioxypyrovalerone, cocaine, amphetamine, cathinones, MDMA, and cannabinoids as investigated by ROAR Forensics laboratory, UK. Other deaths related to AMT have been reported in the US ,Isle of Man, Sweden, Norway, Scotland, UK, and Japan.
    [Show full text]
  • Cocaine Use in Ireland: an Exploratory Study
    Cocaine Use In Ireland: An Exploratory Study Chapter 3 Cocaine Use In Ireland: An Exploratory Study Paula Mayock 3.1 Introduction In Ireland the heroin epidemic of the 1980s, coupled with the public health crisis of HIV transmission through unsafe injecting practices, resulted in a concentration of attention on 'high-risk' drug use categories, most notably heroin and other intravenous drug use. The major focus in the domains of drug policy, treatment and research centred on the 'threats' posed by enduring patterns of drug use, unsafe methods of drug administration and associated risk behaviours. Heroin, being a dominant drug of misuse among individuals receiving treatment, certainly in the greater Dublin area (O'Brien, Moran, Kelleher & Cahill, 2000), has attracted by far the greatest level of interest and attention. This situation is by no means unique to Ireland. As Egginton & Parker (2000) have remarked, 'so distinctive is the impact of this drug that heroin has its own epidemiology' (Egginton & Parker, 2000: 7). In practice, prevalence studies and other empirical research focus on groups, such as opiate users or injectors, who are of concern at a particular time (Frischer & Taylor, 1999). Put differently, attention to particular forms of drug use is very much a function of the drug- political situation in any given jurisdiction (Cohen, 1996). Despite heroin's prominence, publicity and official concern, the past decade has witnessed increased recognition of the pervasiveness of drug use in society generally. Drug use, traditionally associated with social and economic disadvantage, is increasingly recognised as a widespread social phenomenon and is clearly no longer confined to marginalised communities.
    [Show full text]